Literature DB >> 7451650

Prolylcarboxypeptidase (angiotensinase C) in human lung and cultured cells.

K Kumamoto, T A Stewart, A R Johnson, E G Erdös.   

Abstract

The activity of prolylcarboxypeptidase (PCP), or angiotensinase C, was measured in lung tissues, leukocytes, and cultured human cells using Cbz-Pro-[14C]Ala as a substrate. A lysosomal fraction of homogenized rat or human lung contained most of the PCP activity in that tissue. Polymorphonuclear neutrophils, macrophages, and lymphocytes isolated from human blood had PCP activity. Fibroblasts cultured from human tissues had the highest activity (0.56-1.15 mumol/h per 10(6) cells), more than endothelial cells cultured from human pulmonary arteries. PCP of cultured human fibroblasts was similar to the human renal enzyme because it was resistant to moderate heating and was not inhibited by p-chloromercuriphenyl sulfonic acid. These properties and the substrate specificity distinguish PCP from cathepsin A, which is also in fibroblasts. Antibody to human renal PCP reacted with fibroblast PCP in immunofluorescence, indicating common antigenic determinants. Hydrocortisone changed PCP activity in fibroblasts in parallel with changes in beta-glucuronidase activity and cell-protein concentration; the activity was depressed at low concentration of the hormone. PCP activity was also found in synovial fluid from arthritic joints and in fibroblasts from the synovium. That PCP is found in both inflammatory exudates and in cells that appear at sites of inflammation indicates that, in addition to inactivating angiotensins, this enzyme may have a role in inflammation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7451650      PMCID: PMC371589          DOI: 10.1172/JCI110015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Angiotensinase activity of dipeptidyl aminopeptidase I (cathepsin C) of rat liver.

Authors:  J K McDonald; B B Zeitman; P X Callahan; S Ellis
Journal:  J Biol Chem       Date:  1974-01-10       Impact factor: 5.157

3.  Detection of a lysosomal carboxypeptidase and a lysosomal dipeptidase in highly-purified dipeptidyl aminopeptidase I (cathepsin C) and the elimination of their activities from preparations used to sequence peptides.

Authors:  J K McDonald; B B Zeitman; S Ellis
Journal:  Biochem Biophys Res Commun       Date:  1972-01-14       Impact factor: 3.575

4.  Isolation and some properties of cathepsin A from bovine spleen.

Authors:  A I Logunov; V N Orekhovich
Journal:  Biochem Biophys Res Commun       Date:  1972-02-16       Impact factor: 3.575

5.  Nature of lysosomal angiotensinase activity.

Authors:  M Matsunaga
Journal:  Jpn Circ J       Date:  1971-03

6.  New enzymatic route for the inactivation of angiotensin.

Authors:  H Y Yang; E G Erdös; T S Chiang
Journal:  Nature       Date:  1968-06-29       Impact factor: 49.962

7.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

8.  Stabilization of pig kidney cathepsin A by sucrose and chloride ion, and inhibition of the enzyme activity by diisopropyl fluorophosphate and sulfhydryl reagents.

Authors:  E Doi
Journal:  J Biochem       Date:  1974-04       Impact factor: 3.387

9.  Purification of lysosomal prolycarboxypeptidase angiotensinase C.

Authors:  T Kakimoto; G Oshima; H S Yeh; E G Erdös
Journal:  Biochim Biophys Acta       Date:  1973-03-15

10.  Cathepsin A in human brain and spleen.

Authors:  D M Bowen; A N Davison
Journal:  Biochem J       Date:  1973-02       Impact factor: 3.857

View more
  19 in total

1.  Influence of a novel inhibitor (UM8190) of prolylcarboxypeptidase (PRCP) on appetite and thrombosis.

Authors:  F M Rabey; R S V S Gadepalli; S Diano; Q Cheng; T Tabrizian; D Gailani; J M Rimoldi; Z Shariat-Madar
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

2.  Ghrelin regulates hypothalamic prolyl carboxypeptidase expression in mice.

Authors:  Jin Kwon Jeong; Jung Dae Kim; Sabrina Diano
Journal:  Mol Metab       Date:  2013-01-11       Impact factor: 7.422

Review 3.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 4.  Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: from basic to translational research.

Authors:  Markus Böhm; Susanne Grässel
Journal:  Endocr Rev       Date:  2012-06-26       Impact factor: 19.871

Review 5.  Alpha-melanocyte stimulating hormone: production and degradation.

Authors:  Giuseppe D'Agostino; Sabrina Diano
Journal:  J Mol Med (Berl)       Date:  2010-07-10       Impact factor: 4.599

6.  Prolylcarboxypeptidase deficiency is associated with increased blood pressure, glomerular lesions, and cardiac dysfunction independent of altered circulating and cardiac angiotensin II.

Authors:  Christoph Maier; Ines Schadock; Philipp K Haber; Jan Wysocki; Minghao Ye; Yashpal Kanwar; Christopher A Flask; Xin Yu; Brian D Hoit; Gregory N Adams; Alvin H Schmaier; Michael Bader; Daniel Batlle
Journal:  J Mol Med (Berl)       Date:  2017-02-03       Impact factor: 4.599

7.  Prolyl carboxypeptidase and its inhibitors in metabolism.

Authors:  Jin Kwon Jeong; Sabrina Diano
Journal:  Trends Endocrinol Metab       Date:  2012-12-12       Impact factor: 12.015

8.  Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase.

Authors:  Stephen M Soisson; Sangita B Patel; Pravien D Abeywickrema; Noel J Byrne; Ronald E Diehl; Dawn L Hall; Rachael E Ford; John C Reid; Keith W Rickert; Jennifer M Shipman; Sujata Sharma; Kevin J Lumb
Journal:  BMC Struct Biol       Date:  2010-06-11

Review 9.  The kallikrein-kinin system as a regulator of cardiovascular and renal function.

Authors:  Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

10.  Upregulation of prolylcarboxypeptidase (PRCP) in lipopolysaccharide (LPS) treated endothelium promotes inflammation.

Authors:  My-Linh Ngo; Fakhri Mahdi; Dhaval Kolte; Zia Shariat-Madar
Journal:  J Inflamm (Lond)       Date:  2009-01-27       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.